Postinfarction left ventricular remodelling: where are the theories and trials leading us?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation.Cardiology and therapy · 2024
   Article
2. The ST2/IL-33 Pathway in Adult and Paediatric Heart Disease and Transplantation.Biomedicines · 2023
   Review
3. Soluble ST2 in coronary artery disease: Clinical biomarkers and treatment guidance.Frontiers in cardiovascular medicine · 2022
   Review
4. Effect of Guanxin V in animal model of acute myocardial infarction.BMC complementary medicine and therapies · 2021
   Article
5. Mitral Plasticity: The Way to Prevent the Burden of Ischemic Mitral Regurgitation?Frontiers in cardiovascular medicine · 2021
   Review
6. Estrogen Deprivation and Myocardial Infarction: Role of Aerobic Exercise Training, Inflammation and Metabolomics.Current cardiology reviews · 2020
   Review
7. Left ventricular restoration devices post myocardial infarction.Heart failure reviews · 2018
   Review
8. Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research.Molecular and cellular biochemistry · 2017
   Review
9. Cardiac Findings of Pulmonary Thromboembolism by Autopsy: A Review of 48 Cases.Medical science monitor : international medical journal of experimental and clinical research · 2016
   Article
10. Admission glucose and left ventricular systolic function in non-diabetic patients with acute myocardial infarction.Heart and vessels · 2016
    Article
11. The CD4(+) AT2R(+) T cell subpopulation improves post-infarction remodelling and restores cardiac function.Journal of cellular and molecular medicine · 2015
    Article
12. Resistance training after myocardial infarction in rats: its role on cardiac and autonomic function.Arquivos brasileiros de cardiologia · 2014
    Article
13. Postmyocardial infarct remodeling and heart failure: potential contributions from pro- and antiaging factors.Cardiology research and practice · 2011
    Article
14. Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2.British journal of pharmacology · 2011
    Article
15. The aging heart and post-infarction left ventricular remodeling.Journal of the American College of Cardiology · 2011
    Review
16. Roles of ghrelin in left-ventricular remodelling after acute myocardial infarction.Heart Asia · 2010
    Article
17. Prevention of Left Ventricular Remodeling After Myocardial Infarction.Current treatment options in cardiovascular medicine · 2002
    Article
18. Cardioprotection by an anti-MASP-2 antibody in a murine model of myocardial infarction.Open heart
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as